As of 2025-07-13, the Relative Valuation of Knight Therapeutics Inc (GUD.TO) is 3.55 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 6.13 CAD, the upside of Knight Therapeutics Inc based on Relative Valuation is -42.1%.
The range of the Relative Valuation is 2.95 - 4.12 CAD.
| Range | Selected | |
| Trailing P/E multiples | 28.1x - 37.1x | 32.6x |
| Forward P/E multiples | 33.0x - 44.9x | 39.0x |
| Fair Price | 2.95 - 4.12 | 3.55 |
| Upside | -51.9% - -32.8% | -42.1% |
| Date | P/E |
| 2025-07-11 | 55.20 |
| 2025-07-10 | 55.29 |
| 2025-07-09 | 54.93 |
| 2025-07-08 | 54.75 |
| 2025-07-07 | 54.39 |
| 2025-07-04 | 54.48 |
| 2025-07-03 | 54.21 |
| 2025-07-02 | 54.03 |
| 2025-06-30 | 52.50 |
| 2025-06-27 | 51.78 |
| 2025-06-26 | 51.78 |
| 2025-06-25 | 51.87 |
| 2025-06-24 | 52.23 |
| 2025-06-23 | 52.32 |
| 2025-06-20 | 52.68 |
| 2025-06-19 | 52.59 |
| 2025-06-18 | 53.49 |
| 2025-06-17 | 54.66 |
| 2025-06-16 | 54.21 |
| 2025-06-13 | 54.30 |
| 2025-06-12 | 54.84 |
| 2025-06-11 | 54.03 |
| 2025-06-10 | 54.39 |
| 2025-06-09 | 54.21 |
| 2025-06-06 | 54.03 |
| 2025-06-05 | 54.21 |
| 2025-06-04 | 52.41 |
| 2025-06-03 | 52.23 |
| 2025-06-02 | 51.78 |
| 2025-05-30 | 51.87 |
| 2025-05-29 | 51.78 |
| 2025-05-28 | 51.87 |
| 2025-05-27 | 52.23 |
| 2025-05-26 | 52.41 |
| 2025-05-23 | 52.14 |
| 2025-05-22 | 51.87 |
| 2025-05-21 | 51.87 |
| 2025-05-20 | 51.96 |
| 2025-05-16 | 52.23 |
| 2025-05-15 | 52.59 |
| 2025-05-14 | 52.05 |
| 2025-05-13 | 52.32 |
| 2025-05-12 | 52.77 |
| 2025-05-09 | 51.42 |
| 2025-05-08 | 51.15 |
| 2025-05-07 | 54.66 |
| 2025-05-06 | 54.84 |
| 2025-05-05 | 54.75 |
| 2025-05-02 | 55.57 |
| 2025-05-01 | 55.20 |